Clovis Oncology Announces Second Quarter 2015 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Clovis Oncology (CLVS) Misses Q2 EPS by 1c
August 6, 2015 4:17 PM EDTClovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($2.10), $0.01 worse than the analyst estimate of ($2.09).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
... More